Think the impossible: β-blockers for treating asthma

Clinical Science

Volumn 118, Issue 2, 2010, Pages 115-120

  Lipworth, Brian J ^a   Williamson, Peter A ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

blocker; Adrenoceptor; Airway hyper responsiveness; Asthma; Bronchoconstriction; Heart failure; Smooth muscle

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CELIPROLOL; CORTICOSTEROID; FLUTICASONE; IPRATROPIUM BROMIDE; METOPROLOL; NADOLOL; PROPRANOLOL; SALBUTAMOL; TIMOLOL;

ADD ON THERAPY; ANTIINFLAMMATORY ACTIVITY; ANXIETY DISORDER; ARTICLE; ASTHMA; BETA ADRENERGIC RECEPTOR BLOCKING; BINDING AFFINITY; BRADYCARDIA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC DRUG ADMINISTRATION; CLINICAL TRIAL; DISEASE EXACERBATION; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; FORCED EXPIRATORY VOLUME; HEART FAILURE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MIGRAINE; NONHUMAN; ORTHOSTATIC HYPOTENSION; PATIENT SELECTION; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; RECEPTOR OCCUPANCY; SINGLE DRUG DOSE;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHOCONSTRICTION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; HEART FAILURE; HUMANS; MICE;

EID: 70549098583     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20090398     Document Type: Article

References (28)

1. British Thoracic Society Scottish Intercollegiate Guidelines Network (2006) British Guideline on the Management of Asthma. Thorax 63 (Suppl. 4) iv1-iv121
2. Salpeter, S. R., Buckley, N. S., Ormiston, T. M. and Salpeter, E. E. (2006) Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma-related deaths. Ann. Intern. Med. 144, 904-912
3. Thomas, M., von Ziegenweidt, J., Lee, A. J. and Price, D. (2009) High-dose inhaled corticosteroids versus add-on long-acting β-agonists in asthma: an observational study. J. Allergy Clin. Immunol. 123, 116-121
4. Gibson, P. G., Powell, H. and Ducharme, F. M. (2007) Differential effects of maintenance long-acting β-agonist and inhaled corticosteroid on asthma control and asthma exacerbations. J. Allergy Clin. Immunol. 119, 344-350
5. Kramer, J. M. (2009) Balancing the benefits and risks of inhaled long-acting β-agonists: the influence of values. N. Engl. J. Med. 360, 1592-1595
6. 2-adrenoceptor agonists: a smart choice for asthma? Trends Pharmacol. Sci. 28, 257-262
7. 2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol. Thorax 61, 940-944
8. 2-adrenoceptor polymorphism predisposes to bronchoprotective subsensitivity in patients treated with formoterol and salmeterol. Br. J. Clin. Pharmacol. 57, 68-75
9. 2-Adrenergic receptor genotype and survival among patients receiving β-blocker therapy after an acute coronary syndrome. JAMA, J. Am. Med. Assoc. 294, 1526-1533
10. 2-adrenoceptor antagonism of betaxolol and atenolol. Eur. J. Clin. Pharmacol. 40, 467-471
11. Salpeter, S. R., Ormiston, T. M. and Salpeter, E. E. (2002) Cardioselective β-blockers in patients with reactive airway disease: a meta-analysis. Ann. Intern. Med. 137, 715-725
12. Fryer, A. D. and Jacoby, D. B. (1998) Muscarinic receptors and control of airway smooth muscle. Am. J. Respir. Crit. Care Med. 158, S154-S160
13. Wisler, J. W., DeWire, S. M., Whalen, E. J., Violin, J. D., Drake, M. T., Ahn, S., Shenoy, S. K. and Lefkowitz, R. J. (2007) A unique mechanism of β-blocker action: carvedilol stimulates β-arrestin signaling. Proc. Natl. Acad. Sci. U.S.A. 104, 16657-16662
14. Hall, S. A., Cigarroa, C. G., Marcoux, L., Risser, R. C., Grayburn, P. A. and Eichhorn, E. J. (1995) Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with β-adrenergic blockade. J. Am. Coll. Cardiol. 25, 1154-1161
15. Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M. and Shusterman, N. H. (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med. 334, 1349-1355
16. Bond, R. A. (2001) Is paradoxical pharmacology a strategy worth pursuing? Trends Pharmacol. Sci. 22, 273-276
17. Callaerts-Vegh, Z., Evans, K. L., Dudekula, N., Cuba, D., Knoll, B. J., Callaerts, P. F., Giles, H., Shardonofsky, F. R. and Bond, R. A. (2004) Effects of acute and chronic administration of β-adrenoceptor ligands on airway function in a murine model of asthma. Proc. Natl. Acad. Sci. U.S.A. 101, 4948-4953
18. 2-adrenoceptor and other signaling proteins produced by chronic administration of 'β-blockers' in a murine asthma model. Pulm. Pharmacol. Ther. 21, 115-124
19. Nguyen, L. P., Omoluabi, O., Parra, S., Frieske, J. M., Clement, C., Ammar-Aouchiche, Z., Ho, S. B., Ehre, C., Kesimer, M., Knoll, B. J. et al. (2008) Chronic exposure to β-blockers attenuates inflammation and mucin content in a murine asthma model. Am. J. Respir. Cell. Mol. Biol. 38, 256-262
20. 2-Adrenoceptor signaling is required for the development of an asthma phenotype in a murine model. Proc. Natl. Acad. Sci. U.S.A. 106, 2435-2440
21. Hanania, N. A., Singh, S., El-Wali, R., Flashner, M., Franklin, A. E., Garner, W. J., Dickey, B. F., Parra, S., Ruoss, S., Shardonofsky, F. et al. (2008) The safety and effects of the β-blocker, nadolol, in mild asthma: an open-label pilot study. Pulm. Pharmacol. Ther. 21, 134-141
22. 3 adrenoceptors. Br. J. Pharmacol. 144, 317-322
23. Tan, K. S., Grove, A., Cargill, R. I., McFarlane, L. C. and Lipworth, B. J. (1996) Effects of inhaled fluticasone propionate and oral prednisolone on lymphocyte β 2-adrenoceptor function in asthmatic patients. Chest 109, 343-347
24. 2-adrenoceptor blockade. Br. J. Clin. Pharmacol. 38, 103-108
25. 1-adrenoceptor antagonists. Br. J. Clin. Pharmacol. 25, 433-438
26. Lima, D. R. and Turner, P. (1983) Propranolol increases reduced β-receptor function in severely anxious patients. Lancet ii, 1505
27. Lima, D. R. and Turner, P. (1982) β-Blocking drugs increase responsiveness to prostacyclin in hypertensive patients. Lancet ii, 444
28. Tan, K. S., Grove, A., McLean, A., Gnosspelius, Y., Hall, I. P. and Lipworth, B. J. (1997) Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am. J. Respir. Crit. Care Med. 156, 28-35